Shiffman, M. L., Brau, N., Bourgeois, S., Mathurin, P., Thuluvath, P. J., Fessel, W. J., . . . Subramanian, M. (2016). Su1415 The Tolerability of Sof/VEL for 12 Weeks in >1000 Patients Treated in the ASTRAL-1, ASTRAL-2, and ASTRAL-3 Studies: An Integrated Safety Analysis. Gastroenterology, 150(4), S1093. https://doi.org/10.1016/S0016-5085(16)33692-7

Shiffman, Mitchell L., et al. "Su1415 The Tolerability of Sof/VEL for 12 Weeks in >1000 Patients Treated in the ASTRAL-1, ASTRAL-2, and ASTRAL-3 Studies: An Integrated Safety Analysis." Gastroenterology 150, no. 4 (2016): S1093. https://doi.org/10.1016/S0016-5085(16)33692-7.

Shiffman, Mitchell L., et al. "Su1415 The Tolerability of Sof/VEL for 12 Weeks in >1000 Patients Treated in the ASTRAL-1, ASTRAL-2, and ASTRAL-3 Studies: An Integrated Safety Analysis." Gastroenterology, vol. 150, no. 4, 2016, p. S1093, https://doi.org/10.1016/S0016-5085(16)33692-7.